Product Description: APC 366 is a selective inhibitor of mast cell tryptase (Ki=7.1 μM). APC 366 inhibits antigen-induced early asthmatic response (EAR), late asthmatic response (LAR), and bronchial hyperresponsiveness (BHR) in a sheep model of allergic asthma[1][2].
Applications: COVID-19-immunoregulation
Formula: C22H28N6O4
References: [1]Barrios VE, et al. Tryptase mediates hyperresponsiveness in isolated guinea pig bronchi. Life Sci. 1998;63(26):2295-2303. /[2]Krishna MT, et al. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol. 2001;107(6):1039-1045.
CAS Number: 158921-85-8
Molecular Weight: 440.50
Compound Purity: 99.81
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Ser/Thr Protease